US Justice Department Investigates Researchers

Image: Artville US Justice Department investigators want to know how academic scientists spend their time and the government's money. The department is making quiet inquiries at research institutions to determine how they've used their federal funding. Research executives would not say which schools the Department of Justice (DOJ) has approached, and department officials refuse to comment, as is their policy with matters under investigation. The inquiries could go nowhere, or they could heral

Written byPeg Brickley
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

US Justice Department investigators want to know how academic scientists spend their time and the government's money. The department is making quiet inquiries at research institutions to determine how they've used their federal funding. Research executives would not say which schools the Department of Justice (DOJ) has approached, and department officials refuse to comment, as is their policy with matters under investigation.

The inquiries could go nowhere, or they could herald a return to past cycles of scrutiny by the department, which has enforcement powers anywhere federal dollars are spent. "I don't really know what it is that they're after," says Robert Killoren, incoming president of the National Council of University Research Administrators (NCURA). "It's such a pity. When we talk about accountability for the way our federal funds are spent, we shouldn't be dealing with accountants necessarily. We should be dealing with people who understand scientific research."

ON ALERT ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies